Comparative pharmacokinetics of an adalimumab biosimilar SB5 administered via autoinjector or prefilled syringe in healthy subjects

PURPOSE: The objective of this study was to demonstrate comparable pharmacokinetic (PK), safety, and tolerability parameters of the adalimumab biosimilar SB5 administered via autoinjector (AI) pen or prefilled syringe (PFS). PATIENTS AND METHODS: In this phase 1, randomized, open-label, single-dose,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Donghoon, Lee, Younju, Jeong, Deokyoon, Ellis-Pegler, Rod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225915/
https://www.ncbi.nlm.nih.gov/pubmed/30464411
http://dx.doi.org/10.2147/DDDT.S169082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225915/
https://www.ncbi.nlm.nih.gov/pubmed/30464411
http://dx.doi.org/10.2147/DDDT.S169082

Ejemplares similares